Paro AD Plus

Paroxetine 12.5 mg+ Clonazepam 0.5mg PR Tablets.

Paroxetine + Clonazepam is a combination of two medicines: Paroxetine and Clonazepam which has mood-enhancing and anxiety-lowering effects. Paroxetine is selective serotonin reuptake inhibitor (SSRI) which increases the levels of serotonin, a chemical messenger that improves mood. Clonazepam is a benzodiazepine (BZD) which increases the action of GABA, a chemical messenger that suppresses the abnormal activity of the nerve cells in the brain.

  • Clonazepam
    • An anticonvulsant reduces excitability of neurons to decrease the amplitude of electric activity from normal and secondary epileptogenic limbic tissues.
  • Paroxetine
    • Controls initial phase and maintains against potential relapse of depression.
    • Effectively eliminates panic disorder with or without agoraphobia.
  • Immediate symptoms control with Clonazepam and sustained system control with Paroxetine PR

Description

Paroxetine 12.5 mg+ Clonazepam 0.5mg PR Tablets.

Paroxetine + Clonazepam is a combination of two medicines: Paroxetine and Clonazepam which has mood-enhancing and anxiety-lowering effects. Paroxetine is selective serotonin reuptake inhibitor (SSRI) which increases the levels of serotonin, a chemical messenger that improves mood. Clonazepam is a benzodiazepine (BZD) which increases the action of GABA, a chemical messenger that suppresses the abnormal activity of the nerve cells in the brain.

  • Clonazepam
    • An anticonvulsant reduces excitability of neurons to decrease the amplitude of electric activity from normal and secondary epileptogenic limbic tissues.
  • Paroxetine
    • Controls initial phase and maintains against potential relapse of depression.
    • Effectively eliminates panic disorder with or without agoraphobia.
  • Immediate symptoms control with Clonazepam and sustained system control with Paroxetine PR

Reviews

There are no reviews yet.

Be the first to review “Paro AD Plus”

Your email address will not be published. Required fields are marked *